The Ayush drug licensing authority in Kerala has issued a warning to Pankajakasthuri Herbals India Pvt Ltd for releasing a misleading advertisement without proper approval, in violation of Rule 170. Rule 170 mandates that ayurvedic drug advertisements must receive clearance from the state licensing authority. This action comes despite the contentious past of Rule 170, which has faced temporary suspensions from legal enforcement. Pankajakasthuri Herbals India Pvt Ltd has been reprimanded for not adhering to the regulatory requirements surrounding the promotion of herbal products. This development highlights the importance of following the necessary protocols and obtaining the required approvals before advertising ayurvedic drugs in India. Advertisers and manufacturers in the herbal medicine industry are advised to ensure compliance with all regulations to avoid penalties and maintain consumer trust. Stay informed about the latest updates on ayurvedic drug advertising regulations to operate legally and ethically in the Indian market.